Abstract: Changes of extracellular pH values can have profound effects on neuronal function. For example, the low pH (also called acidosis) generated in brain ischemia causes acute neuronal injury. For years the receptors that detect pH variations surrounding neurons and their physiological/pathological importance remain uncertain. The recent finding that acidosis activates a distinct family of membrane ion channels, the acid-sensing ion channels (ASICs) in both peripheral and central neurons has dramatically changed the view of acidosis-associated signaling and provided a new strategy for therapeutic inventions. Although proton is the only known agonist for the activation of ASICs, a variety of extracellular and intracellular signaling molecules can modulate the activities of ASICs and have profound influence on the functions of these channels in both physiological and pathological processes. The goal of this article is therefore to provide a comprehensive review of the modulators of ASICs that adapt ASIC activity to changes of extracellular and intracellular environments.
INTRODUCTION
subunits of ASICs have been identified: 1a, 1b, 2a, 2b, 3, and 4 [15, 35] , among which 1a, 2a and 2b are expressed in CNS neurons. Functional ASICs are thought to be tetrameric assemblies of homomeric or heteromeric ASIC subunits [35] . However, other data have suggested as many as nine subunits may be required for the assembly of DEG/ENaC cation channels [36] [37] [38] . Studies of the structure of ASICs indicate that ASICs consist of two transmembrane domains (TM1 and TM2) and a large extracellular loop, with the pre-TM2 region essential for ion permeability and the gating of these channels [16, 35, 39] ( Fig. 1) . The homomeric channels composed of ASIC1a are permeant to Ca 2+ , whereas other homomeric or heteromeric ASICs are largely impermeant to Ca 2+ [16, 30, 33] .
A stable pH is critical for normal neuronal function. Like the cells in other tissues, neurons maintain their extra-and intracellular pH levels through H + transporting mechanisms including Na + /H + and Cl -/HCO 3 -systems [for review see [1] ]. In normal brain tissue, for example, extracellular pH (pH o ) is at 7.3 while intracellular pH (pH i ) is at ~7.0 [1] [2] [3] . It has been recognized for many years that pathological conditions including tissue inflammation, ischemic stroke, traumatic brain injury, and epileptic seizure are accompanied by marked reduction of tissue pH, a condition termed acidosis [2, [4] [5] [6] [7] [8] [9] [10] [11] . Although it was assumed that acidosis generated in ischemia is deleterious for neurons [8, 9] , the exact mechanism(s) was largely unknown.
The main functions of ASICs in peripheral sensory neurons include nociception [40] [41] [42] [43] [44] [45] [46] and mechanosensation [47] [48] [49] . It is also suggested that activation of ASICs is involved in taste transduction [50] [51] [52] . The presence of ASICs in the brain, which lacks nociceptors, suggests that these channels have functions beyond nociception. Indeed, recent studies have indicated that ASIC1a is involved in synaptic plasticity, learning and memory [19, 53] , while ASIC2a may be required for the maintenance of retinal integrity [54] and survival of neurons following global ischemia [55] . It has also been demonstrated that activation [30, 33] or sensitization [56] of Ca 2+ -permeable ASIC1a is responsible for acidosis-mediated ischemic brain injury.
Changes in pH o can modulate the activity of a variety of membrane receptors and ion channels. In general, reducing pH o inhibits whereas raising pH o potentiates the activities of the majority of voltage-gated and ligand-gated ion channels. For example, N-methyl-D-aspartate (NMDA) receptor-gated cation channels are strongly inhibited by decreases in pH o [12, 13] . Similarly, glycine receptor-gated chloride channels are inhibited by acidic pH [14] . In contrast to its modulating effect on other channels, recent studies have demonstrated that lowering pH o can, by itself, activate a distinct family of ligandgated cation channels, the acid-sensing ion channels (ASICs), in both peripheral sensory neurons and in neurons of the central nervous system (CNS) [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . This finding has dramatically changed the view of acidosis-associated changes of neuronal function and provided a new target for therapeutic inventions [27] [28] [29] [30] [31] [32] [33] The exact mechanisms by which ASICs serve these functions remain unclear. Under experimental conditions (e.g. in patchclamp recordings), ASICs are activated only by rapid pH drops. The question of whether tissue pH is subject to quick fluctuations of a magnitude sufficient to activate ASICs would be a crucial point in determining the functional significance of these channels [35] . In addition, the currents of most ASIC subtypes desensitize rapidly (after reaching the maximal value, the currents gradually diminish) whereas the effect of ASIC activation could be long-lasting, for example during brain ischemia [30, 57] . How can a transient opening of ASICs generate a long-lasting effect? One possible explanation to this apparent inconsistency is that the properties of ASICs are subjected to modulation by endogenous signaling molecules and biochemical changes associated with pathological conditions. Notably, the expression and/or function of ASICs are dramatically enhanced after peripheral inflammation [58, 59] and following the global ischemia [56] . In addition, FMRFamide and related mammalian peptides like NPFF and
BASIC PROPERTIES OF ASICs
ASICs belong to the degenerin/epithelial Na + channel (DEG/ENaC) superfamily. These channels are cation-selective and diuretic amiloride-sensitive [16, 34] . To date, at least six NPSF potentiate the ASIC activity and reduce the channel desensitization [60, 61] . Also, ischemia related signaling molecules such as arachidonic acid and lactate dramatically enhance the activation of ASICs [62, 63] . Delineating detailed modulation of ASICs by endogenous modulators is thus important for better understanding the precise role of these channels play in various physiological and pathological conditions. In the following discussion, we will focus on the effects of endogenous modulators on ASICs, which, in general, increase the gain in ASIC signaling. Inhibitors of ASICs will also be discussed, given their potential therapeutic implications in the treatment of various diseases associated with tissue acidosis.
Extracellular Modulators

Zn 2+
To date, a number of studies have demonstrated that extracellular Zn 2+ , an endogenous trace element released during neuronal activity [86, 87] , bi-directionally modulates the ASIC activities. Chu et al. showed that Zn 2+ dose-dependently inhibits ASIC currents in cultured mouse cortical neurons at nanomolar concentrations [67] . In Chinese hamster ovary (CHO) cells expressing various combinations of ASIC subunits, Zn 2+ inhibits the currents mediated by homomeric ASIC1a and heteromeric ASIC1a/ASIC2a channels, without affecting currents mediated by homomeric ASIC1b, ASIC2a, or ASIC3 channels. Consistent with ASIC1a-specific inhibition, highaffinity Zn 2+ inhibition is absent in neurons from the ASIC1a knock-out mice. Current-clamp recordings and Ca 2+ -imaging experiments demonstrated that Zn 2+ inhibits acid-induced membrane depolarization and the increase of intracellular Ca 2+ . Mutation of lysine-133 in the extracellular domain of the ASIC1a subunit abolishes the high-affinity Zn 2+ inhibition [67] . Thus, for homomeric ASIC1a channels, Zn 2+ has only an inhibitory effect through its interaction with the high-affinity binding site(s) (involving K133) on the ASIC1a subunit, resulting in reduced affinity for proton binding to the channels.
DYNAMIC REGULATION OF ASICs
To date, the only known activators of ASICs are protons, though the existence of other still unknown endogenous agonist(s) cannot be ruled out. For instance, a recent study suggests that the ASIC1a channels could also be gated by ammonium [64] . In particular, a millimolar concentration of NH 4 Cl directly activates ASIC currents in midbrain dopamine neurons, and in HEK 293 cells that endogenously express the ASIC1 subunit.
For ASIC1a/ASIC2a channels, however, a complex bidirectional modulation by Zn 2+ exists. At low nanomolar concentrations, Zn 2+ inhibits the channel by binding to the high-affinity site on the ASIC1a subunit. This inhibition saturates at high nanomolar concentrations. As the concentration increases to high micromolar (>100 µM), Zn 2+ binds to low-affinity site(s) on the ASIC2a subunit, resulting in increased affinity for proton binding and potentiation of the ASIC currents [66] . Site-directed mutagenesis studies demonstrate that His-162 and His-339 in the extracellular loop of the ASIC2a subunit, are involved in the Zn 2+ potentiation of the ASIC2a and ASIC2a containing channels [66] .
The sensitivity to pH o and the activation/inactivation kinetics vary according to the ASIC subtypes and the subunit composition of the channel complex, with pH 50 ranging from 4.0 to 6.5 and activation thresholds for most ASICs close to pH 7.0 [16, 35] (but see [65] ). However, various factors, discussed below could modulate ASICs and significantly change the dynamics of these channels. These include trace element Zn 2+ [66] [67] [68] , redox reagents [69, 70] , FMRFamide and RFamiderelated peptides [60, 71, 72] , di-and polyvalent cations [73] [74] [75] [76] , proteases and ischemia-related signaling molecules [62, 63, 77, 78] , intracellular accessory proteins [79] [80] [81] [82] , protein kinase A (PKA) [83] , protein kinase C (PKC) [84, 85] and Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) [56] .
Homomeric ASIC1a and heteromeric ASIC1a/ASIC2a channels are the most common configurations of ASICs in brain regions such as hippocampus that contains large amount of Zn 2+ [16, 19, 26, 88] , suggesting that ASICs might be a physiological target of Zn 2+ . Indeed, micromolar concentrations of Zn 2+ facilitate the proton-gated currents and membrane depolarization in cultured [66] and acutely dissociated hippocampal neurons [68] . In addition to increasing the current amplitude, higher concentrations of Zn 2+ (>100 µM) also slow the inactivation kinetics of the ASIC-like currents in hippocampal neurons [68] . may partially explain the increased neuronal excitation and toxicity seen with high concentrations of extracellular Zn 2+ [93] .
Ca 2+ and Other Cations
In addition to Zn 2+ , a number of di-or tri-valent cations including Ca 2+ , Cu 2+ , Mg 2+ , Pb 2+ , Ni 2+ , Cd 2+ , and Gd 3+ have been shown to modulate the ASIC activities. The effect of Ca 2+ modulation of ASICs depends on whether Ca 2+ is co-applied with acid solution or pre-applied before the channel activation. Co-application of Ca 2+ with acid solution reduces the ASIC currents [16, 45, 68, 75, 94] . Similarly, pretreatment followed by continuous presence of the extracellular Ca 2+ inhibits the ASIC currents [95, 96] . However, pretreatment with Ca 2+ before activation of ASICs in the absence of Ca 2+ enhances the ASIC responses [73, 96] . Caution, however, needs to be taken in performing such experiment since dropping Ca 2+ itself may activate a separate non-selective cation current in neurons and other cells [97, 98] . Some studies have been performed to investigate the mechanism underlying the Ca 2+ modulation of ASICs. A widely accepted explanation is that Ca 2+ decreases the affinity of ASICs for H + [73, 75] . For ASIC3 channels, Immke and McCleskey performed detailed studies to examine the interaction between H + and Ca 2+ [75] . They proposed a model in Although the exact concentration of Zn 2+ at synaptic cleft is not clear, recent cloning of Zn 2+ transporters in mammalian brains [89] and the finding of both high-and low-affinity Zn 2+ uptake mechanisms at neuronal presynaptic terminals [87, [90] [91] [92] strongly suggest that a dynamic change in Zn 2+ concentration might be possible. Therefore, at nanomolar concentrations, Zn 2+ may play an important role in a negative feedback system for preventing/reducing over-excitation of neurons during normal synaptic transmission and ASIC1a-mediated acidotoxicity in pathological conditions. When the concentration of extracellular Zn 2+ reaches high micromolar (e.g., >100 µM), however, an enhancement rather than inhibition of the ASIC1a/ASIC2a channels takes place. This enhancement which binding of H + to ASIC3 displaces the Ca 2+ from its binding site, leading to the opening of the channel [75] . At a pH of 7.4, the ASIC3 channel is closed because of the Ca 2+ blockade. Lowering pH o opens the channel by catalyzing relief of the Ca 2+ blockade by protons. For ASIC1a channels, however, modifications to the model have been made by two recent studies [76, 94] . Paukert and colleagues showed that two negatively charged residues near the entrance of the channel pore, E425 and D432, are crucial for the Ca 2+ blockade of the ASIC1a channel [94] . They proposed that more than one Ca 2+ binding site, one that mediates blocking and one mediates modulation, exist on this channel. Based on the data from the single-channel recordings in heterologous expression systems, studies by Zhang et al . suggest that Ca 2+ modulates the ASIC1 channel in an allosteric manner [76] . At high concentrations, Ca 2+ has an additional effect of voltage-dependent blockade on the channel. multiple ASIC subunits indicate that 1 mM extracellular Ni 2+ specifically inhibits homomeric ASIC1a and heteromeric ASIC1a/ASIC2a channels, whereas 1 mM extracellular Cd 2+ inhibits homomeric ASIC2a, ASIC3, heteromeric ASIC1a/ASIC2a, ASIC1a/ASIC3, and ASIC2a/ASIC3 channels. Both the fast and the sustained phases of the ASIC3 current are sensitive to Cd 2+ inhibition [101] .
In summary, endogenous and exogenous di-and polyvalent cations represent the largest categories of ASIC modulators ( Fig. 2 & Table 1 ). Mechanisms underlying the interactions between these multivalent cations and ASICs may provide valuable clues for the design of therapeutic agents against excitotoxic and acidotoxic neuronal damage.
Redox Reagents
Redox status is known to affect the functions of various voltage-gated and ligand-gated ion channels [102] [103] [104] [105] [106] . This oxidation/reduction-dependent modulation of ion channel function is important because the redox status changes dramatically in physiological/pathological conditions [107] [108] [109] . Two recent studies indicate that reducing agents potentiate, whereas the oxidizing agents inhibit the ASIC currents in both central and peripheral neurons [69, 70] . In CNS neurons and in CHO cells expressing different ASICs, redox modulation is ASIC1a specific [70] . Site-directed mutagenesis studies identified involvement of cysteine 61 and lysine 133, located in the extracellular domain of the ASIC1a subunit, in the modulation of ASICs by oxidizing and reducing agents, respectively. Consistent with redox modulation of ASIC current, in current-clamp recordings and Ca 2+ -imaging experiments, the reducing agents increase whereas the oxidizing agents decrease the acid-induced membrane depolarization and the intracellular Ca 2+ accumulation [70] . These data suggest that redox status of the ASIC1a subunit is an important factor in determining the overall physiological function and pathological role of ASICs in CNS. Given the fact that excessive activation of ASIC1a is highly associated with acidosisinduced neuronal injury [30, 33, 56] , it is conceivable that targeting the redox modulating sites of the ASIC1a subunit may provide an insight into the development of novel therapeutic strategies for ischemic brain injury.
The effect of Mg 2+ on ASICs is comparable to that of Ca 2+ . In heterologous expression system, sequential application of Mg 2+ and low pH produces dose-dependent and voltageindependent potentiation of ASIC1 [73] . For ASIC3, Mg 2+ dosedependently reduces the channel activity when co-applied with acidic solutions, which is similar to the effect of Ca 2+ [75] .
Cu 2+ is the third abundant trace element in human body. A recent study demonstrates a modulatory effect of this divalent cation on ASICs in cultured hypothalamic, hippocampal and cortical neurons [99] . Cu 2+ dose-dependently inhibits the amplitude of ASIC currents, and slows down the current desensitization. Furthermore, micromolar concentrations of Cu 2+ attenuate the acid-induced membrane depolarization. Thus Cu 2+ may be another endogenous modulator of ASIC channels in the CNS, which could negatively modulate the increased neuronal excitability caused by the activation of ASICs.
Pb 2+ is a well-known toxic metal ion that produces multifaceted harmful effects in the CNS. A variety of membrane receptors and ion channels including ASICs are proposed to mediate the toxicity of Pb 2+ . In acutely dissociated CNS neurons, Pb 2+ inhibits ASIC currents in a dose-dependent and voltage-independent manner [96] . Pb 2+ also decreases the ASICmediated increase in intracellular Ca 2+ , and attenuates the acidinduced membrane depolarization. Since activation of ASICs is involved in normal synaptic function, Pb 2+ -induced inhibition of ASICs may therefore contribute to Pb 2+ induced neurotoxicity. In CHO cells transfected with various ASIC subunits, ASIC1a, ASIC1b and ASIC3 subunits are sensitive to the inhibition of Pb 2+ . Since ASIC1b and ASIC3 are expressed only in peripheral sensory neurons, ASIC1a appears to be an important molecular target for Pb 2+ in the CNS. The subunitspecific effect of Pb 2+ on ASICs in the CNS may prove to be a useful tool in identifying the involvement of the ASIC1a subunit in CNS neurons [96] .
FMRFamide and RFamide-Related Peptides
FMRFamide and related peptides were generally considered to play their roles through G-protein coupled receptors [110] . However, two ionotropic receptors involved in the functions of these peptides have been recently identified. FMRFamide-gated Na + channel (FaNaC), which is a neuronal Na + channel in invertebrate, is directly activated by micromolar concentrations of FMRFamide and RFamide-related peptides (RFRPs) [110] . In addition, ASICs, which share significant structure and sequence homology with FaNaC in the mammalian nervous system, can be modulated by FMRFamide and RFRPs. FMRFamide, and RFRPs such as neuropeptide FF (NPFF, FLFQPQRFamide) are not able to generate any ASIC current on their own but significantly potentiate the ASIC currents in sensory neurons and in heterologous expression systems [60, 71, 72] . In addition to their effects on the amplitude of ASIC currents, FMRFamide and RFRPs also dramatically reduce the rate of current desensitization [60, 71, 72] . Studies using knockout mice have demonstrated that ASIC3 plays a major role in the RFamide modulation of proton-gated currents in sensory neurons [71, 111] . In contrast, contribution of ASIC1a to the effect of these peptides appears to be very modest in dosal root ganglion (DRG) neurons, whereas ASIC2a does not seem to play a role in the modulation of ASIC currents by the peptides [71] . These data are consistent with the effects of FMRFamide and related peptides on homomeric ASIC1a and ASIC3 channels expressed in heterologous system [60] . Though ASIC2a is not directly Trivalent metal ion Gd 3+ has been reported to inhibit both the fast phase and the sustained component of the ASIC currents mediated by homomeric ASIC3 and heteromeric ASIC2a/ASIC3 channels in heterologous expression system [74] . Since Gd 3+ has previously been used as a blocker for stretch activated responses in neurons [100] , the inhibition of ASIC3 and ASIC2a/ASIC3 currents by Gd 3+ might therefore suggest an involvement of ASIC3 containing channels in the transduction of mechanosensory stimuli [74] .
Like Pb 2+ and Gd 3+ , Ni 2+ and Cd 2+ are also neurotoxic heavy metal ions that affect various membrane ion channels and receptors. A recent report has demonstrated that both Ni 2+ and Cd 2+ rapidly and reversibly inhibit ASIC activity in a dosedependent manner by decreasing the pH-sensitivity of the channel [101] . The data from CHO cells transfected with Unknown Inhibition [178] modulated by the peptides, the presence of ASIC2a subunits has been shown to enhance the peptide modulation of both ASIC1a-containing and ASIC3-containing channels [72, 112] .
findings suggest that ASICs may represent novel targets in the search of new analgesic agents for pain management.
Proinflammatory mediators such as nerve growth factor (NGF), TNF, histamine, bradykinin, serotonin, interleukin-1 (IL-1), substance P, and PGE2 are pro-nociceptive agents, as they sensitize the nociceptive fibers [122] . Though detailed mechanisms underlying the sensitization remain unclear, earlier studies have demonstrated that the excitatory effects of protons on sensory neurons are markedly potentiated by these proinflammatory mediators [123, 124] . In addition, NGF is required for long-term up-regulation of proton-induced excitation of DRG neurons [125] . These findings suggest that the proinflammatory mediators may have an effect on expression and/or activity of ASICs in nociceptors. Indeed, studies by Mamet and colleagues provided intriguing evidence that the majority of pro-inflammatory mediators stimulate the expression and increase the activities of ASICs [58] . At concentrations equivalent to inducing tissue inflammation, NGF, serotonin, IL-1, and bradykinin can induce increases of ASIC1a, ASIC1b, ASIC2b, and ASIC3 expression in cultured DRG neurons to 3 -10 folds of the basal level [58] . Electrophysiological recordings demonstrated that the percentage of cultured DRG neurons expressing ASIC current and the current density of those neurons were increased following the treatment with a mix of pro-inflammatory mediators [58] . In contrast to the dramatic increase in ASIC expression, the level of vanilloid receptor I mRNA was unchanged, indicating a specific modulation of ASICs by proinflammatory mediators [58] .
ASICs also show distinct responses to the different peptides. For example, FMRFamide and NPFF have a different effect than neuropeptide SF on the inactivation of ASIC3 current [113] . Similarly, FRRFamide and FMRFamide have a comparable effect on ASIC1a but FRRFamide have a much stronger effect than FMRFamide on the rate of inactivation of the ASIC1b current [60] . The potentiation of ASIC activity by endogenous FMRFamide neuropeptides probably participates in the response of sensory and central neurons to noxious acidosis [60, 110] . There is also a possibility of the existence of still unknown FMRFamide peptides acting as direct agonists for ASICs. An extensive review of the modulation of ASIC by FMRFamide and related peptides is presently available [110] .
Non-Steroid Anti-Inflammatory Drugs and Inflammatory Mediators
Drop of tissue pH, well below the threshold for ASIC activation, is a common feature of tissue inflammation [10, 11] . It is therefore expected that ASICs, particularly the ASIC1a and ASIC3 channels, which have high sensitivity to moderate pH changes, are activated during tissue inflammation and participate in pain sensation. This notion was supported by the finding that local injection of acid activates the nociceptors and produces pain in human subjects [114] [115] [116] [117] . Moreover, the acidinduced pain could be inhibited by the non-selective ASIC blocker amiloride [42, 114, 117] . Furthermore, chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3 [43] . Together, these findings strongly suggest that activation of ASICs may play an important role in the transduction of pain sensation.
Proteases and Ischemia-Associated Molecules
In addition to a decreased pH, which activates the ASICs, various biochemical changes take place in neurological diseases such as brain ischemia and neurotrauma. Alteration in ion homeostasis (Ca 2+ , K + for example), increased protein and lipid metabolism and generation of lipid metabolites (arachidonic acid, for example), and changes in protease activity/concentration, or protein phosphorylation/ dephosphorylation, are among the common biochemical changes associated with brain ischemia. The majority of these changes have been shown to modulate the activities of various voltage-gated and ligand-gated channels. For example, the activities of NMDA receptor-gated channels are modulated by protease [126] , arachidonic acid [127] , and protein phosphorylation [128, 129] . Similarly, the activities of ASICs have also been shown to be modulated by ischemia-related signaling molecules.
Non-steroid anti-inflammatory drugs (NSAIDs) are the most commonly used anti-inflammatory and analgesic agents which constitute a diverse group of chemicals [27] . Although an inhibition of cyclooxygenases (COXs) and reduced synthesis of prostaglandin have been known to be the main mechanism underlying the anti-inflammatory effects of the majority of NSAIDs, various evidence suggested that mechanisms other than COX inhibition play a role in their pain relief capacity. For example, animals with COX knockout still showed sensitivity to analgesic action of NSAIDs [118] . It is known that both Sand R-enantimeres of flurbiprofen are effective in pain relief. Unlike S-form which inhibits COX and prostaglandin synthesis, however, the R-form has much less effect on prostaglandin synthesis [119] . Also, it is apparent that diclofenac has an analgesic effect independent of COX inhibition [120] . It has also been shown that NSAIDs can reduce acid induced cutaneous pain in the absence of inflammation [121] .
Proteases
Brain injury, by ischemia for example, is accompanied by increased protease activity [130] . Blood-derived proteases such as thrombin, tissue plasminogen activator, and plasmin can have access to the interstitial space from compromised bloodbrain barrier [130, 131] . Previous studies have demonstrated that proteases modulate the activities of various ion channels, including ENaC which belongs to the same family as ASICs [126, 132, 133] . It is expected that proteases may have an effect on ASICs. Indeed, recent studies by Poirot and colleagues demonstrated a complex modulation of the function of ASIC1a, but not of ASIC2a and ASIC3, by serine proteases [77] . The exposure of cells to trypsin or other serine proteases (proteinase K and chymotrypsin) shifted the pH dependence of the ASIC1a activation and the steady-state inactivation to more acidic pH values. As a consequence, protease exposure leads to a decrease in the activity of ASIC1a when the current is activated by a pH drop from 7.4. Interestingly, if the channel is activated from a basal pH of 7, protease exposure increases, rather than decreases, the ASIC1a activity. In addition, protease treatment dramatically accelerates the recovery rate of the ASIC1a
This evidence, in conjunction with early finding that proton activates depolarizing inward current in nociceptors [40, 41] and the recent discovery of ASICs as proton receptors in sensory neurons, suggested a strong link between NSAIDs and ASICs. The simple explanation would be that the anti-nociceptive effect of NSAIDs is due, at least partially, to an inhibition of ASIC function. Indeed, studies by Voilley et al. nicely established this link -NSAIDs directly inhibit the activity of ASICs in DRG neurons and in CHO cells at the same concentration range as their therapeutic doses for analgesic effects [59] . Ibuprofen and flurbiprofen, for example, inhibit ASIC1a containing channels with an IC 50 of 350 µM. Aspirin and salicylate inhibit ASIC3 containing channels with an IC 50 of 260 µM, whereas diclofenac inhibits the same channels with an IC 50 of 92 µM. In addition to the direct inhibition of the ASIC activity, NSAIDs largely prevent inflammation induced increase of ASIC expression in sensory neurons [59] . These channels from desensitization [77] . The effects of proteases involve proteolytic activity on the channel protein, as the inhibition of trypsin by soybean trypsin inhibitor or modification of its catalytic site by TLCK prevented trypsin modulation of the ASIC1a. Cleavage of the channel protein was confirmed by Western blot analysis showing a reduction of a 64-kDa protein band with an appearance of a lower molecular weight band of 49 kDa [77] . Further studies demonstrated that trypsin modulates the ASIC1a function by cleaving ASIC1a subunits at Arg-145, which is in the N-terminal part of the extracellular loop. The cleavage site is between a highly conserved sequence and a sequence that is critical for ASIC1a inhibition by psalmotoxin 1 (PcTx1) [78] . potentiation persists in excised membrane patches. Since lactate has the ability to chelate the divalent cations including Ca 2+ and Mg 2+ , and the concentration of extracellular divalent cations, particularly Ca 2+ , has a modulatory role on various membrane receptors and ion channels [151] [152] [153] , the authors hypothesized that potentiation of the ASICs may be due to the chelation of divalent cations. Indeed, adjusting the concentrations of Ca 2+ and Mg 2+ eliminated the effect of lactate, whereas reducing the divalent concentrations mimicked the effect of lactate [62] . In addition, other monocarboxylic acids which have the divalent cation chelation ability also potentiated the ASIC current. Similar to the cardiac sensory neurons, potentiation of the ASIC current by lactate has been reported in other neurons such as the cerebellar Purkinje neurons [63] . It is likely that the bi-directional regulation of ASIC1a function in neurons may allow ASIC1a to adapt its gating to situations of changed extracellular pH, e.g. in ischemia. Since activation of ASIC1a is involved in acidosis-mediated ischemic brain injury [30, 33] , modulation of ASIC1a by proteases could play an important role in the pathology of brain ischemia.
Intracellular Modulators
Protein Kinases
Besides direct modulations by the extracellular factors discussed above, ASICs can be regulated by a variety of intracellular modulators. Baron et al. first showed that PKC activator OAG strongly enhances the ASIC2a current in the presence of protein interacting with C kinase (PICK1). The PICK1-dependent and PKC-induced phosphorylation does not change the kinetics, pH dependence, and the unitary conductance of ASIC2a channels but induces an increase of the channel open probability [84] . Another study demonstrated that ASIC3-like currents in cultured DRG neurons are increased by PKC activator phorbol ester PDBu and pain mediators, such as serotonin, which are also known to activate PKC through their binding to G protein-coupled receptors [85] . It was demonstrated that PKC regulation of ASIC3 involves the ASIC2b subunit, since heteromultimeric ASIC3/ASIC2b channels, but not homomeric ASIC3 channels, are potentiated by PKC. The increase of ASIC3/ASIC2b current is accompanied by a shift in H + dose-response toward more physiological pH values. The up-regulation by PKC also requires the presence of PICK-1, a PDZ domain-containing protein, which interacts with C-terminus of ASIC1a, ASIC2a, and ASIC2b, but not ASIC3 [80, 81, 85] . Point mutations identified involvement of Thr-40 and Ser-523 on ASIC3 subunit in PICK1-dependent PKC modulation of the ASIC3/ASIC2b channels [85] . Association with PICK1 likely provides a mechanism for selective targeting of PKCα to ASIC3 phosphorylation sites. In this process, ASIC2b subunits appear to play an essential regulatory role as a link between the PICK-1/PKC complex and the ASIC3 subunits [85] .
Arachidonic Acid
Arachidonic acid is a major metabolite of membrane phospholipids, which has be shown to be involved in the physiological processes [134, 135] and pathology of various neurological disorders [135] [136] [137] . During brain ischemia, for example, the rise of [Ca 2+ ] i leads to the activation of phospholipase A2 which results in an increased production of arachidonic acid [135, 136, 138] . Earlier studies have shown that arachidonic acid has effects on a variety of voltage-gated and ligand-gated ion channels [139] [140] [141] [142] [143] [144] [145] . For example, it potentiates the opening of NMDA channels [127, 139, 145] . A recent study has shown that arachidonic acid also enhances the ASIC current in rat cerebellar Purkinje neurons [63] . The fractional potentiation by arachidonic acid is not different for ASIC currents activated at pH of 6.7 or 6.0, suggesting that arachidonic acid does not alter the pH-dependence of the activation of ASICs. The potentiation of the ASIC currents appears to be produced directly by arachidonic acid and not by its derivatives, since including an agent known to block the breakdown of arachidonic acid did not affect the potentiation [63] . The mechanism for arachidonic acid potentiation of ASICs is not fully understood. One explanation is that insertion of arachidonic acid into the membrane induce membrane stretch and that the ASICs are stretch-sensitive, as has been proposed for NMDA channels [127] . To support this argument, perfusion of neurons with hypotonic saline which causes cell swelling and membrane stretch mimicked the potentiation of the ASIC current by arachidonic acid [63] .
Lactate
In contrast to other subunits of ASICs, ASIC1a is not phosphorylated by PKC but by PKA. Leonard et al. showed that PKA phosphorylates Ser-479 of ASIC1a. Phosphorylation of ASIC1a by PKA reduces PICK1 binding and attenuates the cluster of ASIC1a in hippocampal neurons. These results suggest that the delivery of ASIC1 subunits is likely regulated by a combination of protein interactions and posttranslational modifications.
Regulation of this interaction by phosphorylation may provide a mechanism to control the cellular localization of ASIC1 [83] .
The switch from aerobic to anaerobic metabolism of glucose during ischemia leads to increased production of lactate. Concentrations of lactate between 12-20 mM have been reported in the extracellular space following ischemia, dramatically higher than the ~ 1 mM lactate in the normal conditions [146, 147] . Earlier studies in whole animal have suggested a likely potentiation of H + induced stimulation of sensory axons by lactic acid [148] [149] [150] . In sensory neurons that innervate the heart, Immke & McCleskey demonstrated that addition of 15 mM lactate dramatically increased the amplitude the ASIC current activated by a moderate pH drop to ~7.0 [62] . Applications of the same concentration of lactate at pH values that do not activate the ASICs (8.0 or 7.4) caused no response. Thus, lactate acts by potentiating but not activating the ASICs. In COS-7 transfected with different subunit of ASICs, both ASIC3 and ASIC1a current were potentiated by lactate [62] . The mechanism for lactate potentiation of the ASIC currents was nicely addressed in the same study. The effect of lactate does not require second messenger or signaling cascade because the Under pathological conditions such as brain ischemia, a novel form of regulation of ASIC1a is mediated by CaMKII [56] . Four-vessel occlusion of rats to produce global brain ischemia results in an increased phosphorylation of ASIC1a. Recruitment of CaMKII to the NR2B subunit of the NMDA receptor allows CaMKII to phosphorylate ASIC1a at Ser-478 and Ser-479 of its C-terminal. This phosphorylation sensitizes the channel to low pH, exacerbating cell death by allowing increased calcium conductance [56] .
In addition to serine/threonine phosphorylation, tyrosine kinase may also be involved in the modulation of ASIC function, though not directly [154] . Because the level of basal expression of ASIC3 depends largely on the constitutive activation of trkA, the NGF-specific receptor, followed by activation of the phospholipase C /PKC pathway [154] . alkalization, dramatically increases the amplitude of the ASIC current. In contrast, the manipulations that cause intracellular acidification, for example, the addition and withdrawal of NH 4 Cl [157, 161] or the bath perfusion of propionate [162, 163] , produce an opposite effect on the ASIC current. The effects of intracellular alkalizing/acidifying agents are also mimicked by using intracellular solutions with the pH directly buffered at high/low values. In addition to affecting the current amplitude, increasing pH i induces a shift in H + dose-response curve toward less acidic pH but a shift in the steady-state inactivation curve toward more acidic pH. Furthermore, alkalizing pH i induces an increase in the recovery rate of ASICs from desensitization. Therefore, the overall effect of decreasing pH i is an inhibition of ASIC activity, whereas the effect of increasing pH i is an enhancement of ASIC activity. Consistent with the changes in ASIC current, acid-induced increases of intracellular Ca 2+ concentration, membrane depolarization, and acidosis-mediated neuronal injury are dramatically affected by the level of pH i .
Postsynaptic Scaffolding Proteins
Similar to most membrane receptors and ion channels, ASICs reside in macromolecular complexes. Several ASICinteracting proteins have been recently identified which may regulate the localization and the function of ASICs. The PDZ domain of PICK1 interacts directly with the C-terminal of ASIC1a, ASIC2a and ASIC2b (homology with type II PDZbinding motif), but not ASIC3 [80, 81, 84] . Interaction with PICK1 facilitates phosphorylation of the ASIC2a subunit and the enhancement of the ASIC2a current by PKC [84] , whereas the interaction between ASIC1a and PICK1 may provide a mechanism to control the cellular localization of this subunit. The synaptic localization of PICK1 and its interaction with ASICs raised the question of whether ASICs are also localized at the synapse. Indeed, co-localization of ASIC1a with PICK1 has been demonstrated at the synapses of cultured hippocampal neurons [81] . A recent study performed in hippocampal slices further confirmed that ASIC1a subunit localizes at dendritic spines, the postsynaptic site of most excitatory synapses [155] . The expression of ASIC1a affects the density of spines; suppressing the ASIC1a expression reduces the number of spines, whereas over-expressing ASIC1a increases the number of spines. Acid application evokes an ASIC1a-dependent elevation of intracellular Ca 2+ concentration at dendritic spines, and an increased activation of CaMKII signaling pathway is likely responsible for the increase of the spine density [155] .
Considering the variable, non-uniform changes of pH o and pH i in ischemic brain [3] , this study may suggest that the activities of ASICs in ischemic brain and ASIC-mediated neuronal injury are non-uniform in different brain regions. In regions where the drop of pH o is accompanied by a normal or alkaline pH i, the activities of ASICs and ASIC-mediated cell injury would be greater than the regions where both pH o and pH i decrease.
ASIC INHIBITORS
Nonselective ASIC Inhibitors
Amiloride, a previously widely used K + -sparing diuretic, is a nonselective blocker of ENaC. It is also used as a nonselective blocker of ASICs which belong to the ENaC superfamily [35] . Micromolar concentrations of amiloride block ASICs in a dose dependent manner [16, 30] . Amiloride has also been shown to decrease ASIC-mediated intracellular Ca 2+ increase and attenuate acid-induced membrane depolarization [30, 33, 45, 164] . When combined with other pharmacological or molecular biological approaches, amiloride can be used as a pharmacological tool to identify ASIC channels even though it is not specific. For ASIC1a, ASIC1b, and ASIC2a subunits, the IC 50 for amiloride inhibition is ~20 µM, whereas slightly higher concentration of amiloride (IC 50 of ~50 µM) is needed for the inhibition of transient ASIC3 current [165] [166] [167] [168] . Unlike the transient current, the sustained component of the ASIC3 current is completely resistant to amiloride blockade. Although the exact site(s) for amiloride effect on individual ASIC remain to be determined, Pre-TM2 region is known to be critical for amiloride blockade of ENaC and ASICs. Gly-430 mutations of ASIC2a, for example, has been shown to dramatically increase the amiloride sensitivity by ~10 fold [168] . As an ASIC blocker, amiloride has been shown to have some therapeutic effects against acid-induced pain in human [42] , and protect CNS neurons against acidotoxic neuronal damage in vitro and in vivo [30] .
The C-terminus of ASIC3 shares homology with type I PDZbinding motifs. Channel-interacting PDZ domain protein (CIPP), which contains four PDZ domains, is reported to interact with the ASIC3 C-terminus and increase H + -gated current [156] . The interaction with CIPP enhances the surface expression of ASIC3, and may bring together ASIC3 and functionally related proteins at the membrane of sensory neurons. Additionally, the PDZ-binding motif at the ASIC3 C-terminus also interacts with four other different proteins that contain PDZ domains: PSD-95, Lin-7b, MAGI-1b, and PIST [82] . Like ASIC3, these interacting proteins are expressed in dorsal root ganglia and spinal cord. However, the outcome of interactions varies with different PDZcontaining proteins. For instance, co-expression with PSD-95 reduces the amplitude of ASIC3 currents, whereas expression of Lin-7b increases the current. PSD-95 and Lin-7b alter the current density by decreasing or increasing, respectively, the amount of ASIC3 expressed on the cell surface [82] .
Intracellular pH
Along with pH o , changes in pH i also take place in both physiological and pathological conditions [2, 6] . It is worth mentioning that, although pH i also drops during ischemia in general, the degree of pH i changes is not homogeneous across all brain regions, and an alkalization of pH i has been demonstrated in cortical penumbra region following focal ischemia [3] . Changing the level of pH i has been shown previously to modulate the activities of several ion channels [157] [158] [159] . Therefore, it is expected that changes in pH i also affect the activities of ASICs. Indeed, in cultured mouse cortical neurons, the overall activities of ASICs, including channel activation, inactivation, and recovery from desensitization, are tightly regulated by the level of pH i [160] . The first evidence suggesting a modulation of ASICs by pH i is the finding that bath perfusion of quinine, an agent known to cause intracellular Recently, Dube and colleagues reported a new small molecule ASIC blocker, A-317567, which is unrelated to amiloride [169] . A-317567 dose-dependently inhibits ASIC1a-like, ASIC2a-like, and ASIC3-like currents in rat DRG neurons. The IC 50 s for blocking ASIC1a-like, ASIC2a-like, and ASIC3-like currents are 2.0, 29.1, and 9.5 µM, respectively. Unlike amiloride, A-317567 equipotently blocks both the fast and the sustained phases of the ASIC3-like current. In both in vitro studies and in vivo pain models, A-317567 appears to be more potent than amiloride [169] .
Subunit-Specific Inhibitors of ASICs
PcTx1 is the first peptide toxin, isolated from the venom of South American tarantula Psalmopoeus cambridgei, that acts specifically on the ASIC1a subunit [170] . It contains 40 amino acids cross-linked by three disulfide bridges. Nanomolar PcTx1 potently inhibits the homomeric assembly of ASIC1a, without affecting other configurations of ASICs. Thus PcTx1 has been used to determine the presence, and the function of homomeric ASIC1a in native neurons [30, 88, 170, 171] . Studies by Chen et al . indicate that PcTx1 inhibits the ASIC1a subunit by increasing its apparent affinity for H + [172] , and that the interaction of PcTx1 with ASIC1a depends on the channel states [173] . It binds tightly to the channel in open and desensitized states, thus promoting channel inactivation. The binding site for PcTx1 has recently been analyzed using radiolabelled tool [174] . It binds principally on cysteine-rich domains I and II (CRDI and CRDII) of the extracellular loop. Although the post-TM1 and pre-TM2 regions are not involved in the binding, they are crucial for the ability of PcTx1 to inhibit ASIC1a current. The linker domain between CRDI and CRDII is important for their correct spatial positioning to form the PcTx1 binding site [174] . In addition to ASIC1a, PcTx1 also interacts with the ASIC1b subunit, a splice variant of ASIC1a. However, it enhances rather than inhibits the activity of ASIC1b. It binds to the ASIC1b in open state, thus promoting the channel opening [173] .
ASICs represent new biological components in peripheral sensory and CNS neurons. Increasing evidence indicates the involvement of these channels in both physiological and pathological processes such as nociception, mechanosensation, taste transduction, synaptic plasticity, learning/memory, and acidosis-mediated neuronal injury. Although in most electrophysiological recordings ASIC responses appear to be transient in nature, various biochemical changes, largely occur in pathological conditions such as brain ischemia, dramatically enhance the amplitude, reduce the desensitization, or increase the recovery of ASICs from desensitization ( Table 1) . Delineating the mechanisms underling the modulation of ASICs by biochemical signaling molecules is, with no doubt, critical for understanding the physiological/pathological roles of these novel channels and for establishing future therapeutic interventions.
